Early Bevacizumab Treatment of Central Retinal Vein Occlusion
Authors:
- Richard F. SpaideRSRichard F. Spaide
- 1 December 2007
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 144 (6) , 864-871
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONSRetina, 2007
- Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT studyDocumenta Ophthalmologica, 2006
- ONE-YEAR SAFETY AND EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- INTRAVITREAL TRIAMCINOLONE ACETONIDE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- Prevalent misconceptions about acute retinal vascular occlusive disordersProgress in Retinal and Eye Research, 2005
- The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)Ophthalmology, 1998
- Vascular endothelial growth factor upregulation in human central retinal vein occlusion11The authors have no proprietary interest in any of the materials used in this study.Ophthalmology, 1998
- Natural History and Clinical Management of Central Retinal Vein OcclusionArchives of Ophthalmology (1950), 1997
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994